FierceBiotech

FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen

BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R ...
FierceBiotech

FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes

The approval of Apidra (R) for pediatric use is based upon FDA review of a 26-week, phase III, open-label, active control study of Apidra (R) in comparison with insulin lispro, in 572 children and ...
Monthly Prescribing Reference

Apidra SoloSTAR insulin pen available

Apidra SoloSTAR (insulin glulisine [rDNA origin] injection, from sanofi-aventis), a prefilled disposable pen containing Apidra, is now available. Apidra SoloSTAR makes administration of insulin more ...
Monthly Prescribing Reference

Apidra approved for pediatric diabetes

The FDA has approved Apidra (insulin glulisine [rDNA origin] injection, from sanofi-aventis) for the treatment of type 1 diabetes in children ≥4 years old. This approval was based on a 26-week, ...